MORGAN STANLEY - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 42 filers reported holding MILLENDO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,000
-50.0%
1,0060.0%0.00%
Q4 2020$2,0000.0%1,006
-6.2%
0.00%
Q3 2020$2,000
-87.5%
1,072
-88.3%
0.00%
Q2 2020$16,000
+220.0%
9,170
+789.4%
0.00%
Q1 2020$5,000
-94.1%
1,031
-91.9%
0.00%
Q4 2019$85,000
+304.8%
12,681
+338.5%
0.00%
Q3 2019$21,000
+250.0%
2,892
+476.1%
0.00%
Q2 2019$6,000
-87.0%
502
-83.5%
0.00%
Q1 2019$46,000
+1433.3%
3,041
+749.4%
0.00%
Q4 2018$3,0003580.00%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$16,145,0004.14%
GREAT POINT PARTNERS LLC 1,288,093$14,891,000,0001.65%
NEA Management Company, LLC 1,766,779$20,424,0001.43%
Bpifrance SA 1,078,670$12,469,0001.34%
ADAMS STREET PARTNERS LLC 409,146$4,730,0000.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$2,056,0000.76%
Prosight Management, LP 73,868$854,0000.43%
Samsara BioCapital, LLC 45,101$521,0000.34%
AWM Investment Company, Inc. 77,629$897,0000.17%
GMT CAPITAL CORP 53,419$618,0000.02%
View complete list of MILLENDO THERAPEUTICS INC shareholders